TGF-b 3 (207 a.a.) Human
Transforming Growth Factor-Beta 3 (207 a.a.) Human Recombinant

Synonyms:
Transforming Growth Factor-beta3, TGFB3, ARVD, FLJ16571, TGF-beta3.

Introduction:
Transforming growth factor betas (TGF Betas) mediate many cell-cell interactions that occur during embryonic development. Three TGF Betas have been identified in mammals. TGF Beta 1, TGF Beta 2 and TGF Beta 3 are each synthesized as precursor proteins that are very similar in that each is cleaved to yield a 112 amino acid polypeptide that remains associated with the latent portion of the molecule. This antibody reacts with the precursor and mature form of TGF Beta 2 and to a lesser extent TGF Beta 3, but does not cross react with TGF Beta 1.

Description:
TGFB3 Human Recombinant protein encoding amino acids 644-850 and total molecular mass of 50 kDa.

Source:
Escherichia Coli.

Physical Appearance:
Sterile Filtered clear solution.

Formulation:
100µl purified human TGF Beta 3protein at 100µg/ml in 50mM Tris-Acetate, pH-7.5, 1mM EDTA and 20% Glycerol.

Stability:
TGF-beta 3 Human Recombinant although stable at 4⁰C for 1 week, should be stored at -20⁰C. For long term storage it is recommended to add a carrier protein (0.1% HSA or BSA).
Please avoid freeze-thaw cycles.

Applications:
(a) ELISA.
(b) Western Blotting.
(c) Inhibition Assays.

Usage:
Prospec's products are furnished for LABORATORY RESEARCH USE ONLY. The product may not be used as drugs, agricultural or pesticidal products, food additives or household chemicals.